Diabetes doesn’t clock off at 5 p.m., and neither do its costs.Every glucose check, clinic visit, or insulin refill carries both a financial and emotional weight, shared unequally between patients, …
June 2025
-
-
What Is Diagnostic Repurposing in IVD and CDx? Diagnostic repurposing in IVD and CDx means reusing an already validated assay, biomarker panel, or analytical platform for a new indication, disease …
-
A Quiet Revolution in Genomic Medicine On 6 May 2025, NHS England quietly published the new National Genomic Test Directory 2025/26, a document that may seem administrative but in reality …
-
On 10 June 2025, the Swiss Federal Office of Public Health (FOPH) announced a new package of amendments to the Healthcare Benefit Ordinance (KLV/OPre), the national instrument that determines what …
-
Discover how vignette studies in healthcare transform HTA, QALY modelling, and patient-centred decision-making by blending evidence and empathy. The Human Core of Evidence-Based Medicine Vignette studies in healthcare represent one …
-
France Redefines Diagnostic Reimbursement with the First AI-Enabled and Genomic Tests Under RIHN 2.0 France has entered a new era of evidence-based reimbursement for diagnostic innovation.On 5 June 2025, the …
-
France’s Bold Frontier: How the Early Access Programme (AAP) is Redefining Hope, Access, and Reimbursement in 2025. It is one of the most sophisticated early access and temporary reimbursement frameworks …